Pharma Industry News

A collection of Pharma latest news, analysis and best practices from top business influencers and the world's most trustworthy sources.

seekingalpha.com - SA Transcripts - SCHOTT Pharma AG & Co. KGaA (SHTPY) Q1 2026 Earnings Call Transcript
SCHOTT Pharma AG & Co. KGaA (SHTPY) Q1 2026 Earnings Call Transcript
Seeking Alpha

SCHOTT Pharma AG & Co. KGaA (SHTPY) Q1 2026 Earnings Call February 11, 2026 5:00 AM EST Tobias Erfurth - Head of Investor Relations Andreas Reisse - Chairman of Management Board & CEO of SCHOTT Pharma Management AG Reinhard Mayer - CFO & Member of…

statnews.com - Elaine Chen - Biotechs, wary of being tied to Big Pharma, form new industry group as hedge against Trump policies
Biotechs, wary of being tied to Big Pharma, form new industry group as hedge against Trump policies
STAT

As President Trump hails pricing agreements with the pharmaceutical industry — and as major drugmakers tout their participation in the TrumpRx website — some biotech companies are worried they have been left out in the cold. Now…

mediabistro.com - Media News - New to The Street Signs Six-Part Media Series Featuring Medicus Pharma Ltd.
New to The Street Signs Six-Part Media Series Featuring Medicus Pharma Ltd.
Mediabistro

New to The Street, the nationally syndicated, long-form television and digital media platform, today announced it has signed a six-part media series with Medicus Pharma Ltd. (NASDAQ:MDCX) ('Medicus' or the 'Company'), a precision guided…

business-standard.com - Capital Market - OneSource Speciality Pharma receives SFDA approval for its generic Ozempic
OneSource Speciality Pharma receives SFDA approval for its generic Ozempic
Business Standard

OneSource Speciality Pharma announced it has received Saudi Food and Drug Authority (SFDA) approval of its generic Ozempic (semaglutide) in Saudi Arabia, clearing the path for commercialsing the product with Hikma Pharmaceuticals PLC (Hikma) as…

business-standard.com - Sanket Koul - US-Bangladesh pact unlikely to impact India's pharma, medtech exports
US-Bangladesh pact unlikely to impact India's pharma, medtech exports
Business Standard

The United States and Bangladesh have finalised a bilateral reciprocal trade agreement aimed at deepening economic ties, but industry executives say it is unlikely to materially impact India's pharmaceutical and medical device exports, despite…

marketbeat.com - Royalty Pharma Q4 Earnings Call Highlights
Royalty Pharma Q4 Earnings Call Highlights
MarketBeat

How Royalty Pharma Prints Cash Without Biotech's Biggest Risks Royalty Pharma NASDAQ: RPRX executives highlighted what they described as a “landmark year” in 2025, pointing to double-digit top-line growth, continued capital deployment…

marketbeat.com - Royalty Pharma (NASDAQ:RPRX) Releases Earnings Results, Misses Expectations By $0.90 EPS
Royalty Pharma (NASDAQ:RPRX) Releases Earnings Results, Misses Expectations By $0.90 EPS
MarketBeat

Royalty Pharma (NASDAQ:RPRX - Get Free Report) posted its quarterly earnings data on Wednesday. The biopharmaceutical company reported $0.38 earnings per share (EPS) for the quarter, missing the consensus estimate of $1.28 by ($0.90), reports. The…

marketbeat.com - Zealand Pharma A/S (OTCMKTS:ZLDPF) Given Consensus Recommendation of 'Buy' by Brokerages
Zealand Pharma A/S (OTCMKTS:ZLDPF) Given Consensus Recommendation of 'Buy' by Brokerages
MarketBeat

Zealand Pharma A/S (OTCMKTS:ZLDPF - Get Free Report) has been given an average rating of 'Buy' by the seven brokerages that are presently covering the firm, Marketbeat Ratings reports. Two analysts have rated the stock with a hold recommendation…

marketbeat.com - Candriam S.C.A. Invests $7.74 Million in BridgeBio Pharma, Inc. $BBIO
Candriam S.C.A. Invests $7.74 Million in BridgeBio Pharma, Inc. $BBIO
MarketBeat

Candriam S.C.A. purchased a new stake in BridgeBio Pharma, Inc. (NASDAQ:BBIO - Free Report) in the third quarter, according to its most recent filing with the Securities and Exchange Commission. The institutional investor purchased 148,986 shares…

marketbeat.com - CorMedix Investor Day: Melinta Deal Fuels Shift to Multi-Product Pharma, Rezzayo Q2 Data Ahead
CorMedix Investor Day: Melinta Deal Fuels Shift to Multi-Product Pharma, Rezzayo Q2 Data Ahead
MarketBeat

High Risk, High Reward: 3 Healthcare Stocks to Watch in 2026 CorMedix NASDAQ: CRMD used its 2026 Analyst and Investor Day to outline its shift from a single-product renal-focused company to what management described as a diversified…

yahoo.com - Muhammad Ali Khalid - Here is Why Amcor (AMCR) is Highly Favored by Hedge Funds
Here is Why Amcor (AMCR) is Highly Favored by Hedge Funds
Yahoo!

Amcor plc (NYSE: AMCR) is one of the 8 best paper and plastic packaging stocks to buy according to hedge funds. On February 4, Ghansham Panjabi at Baird raised his target price on Amcor plc (NYSE:AMCR) from $50 to $54, resulting in a 12% upside.

news-medical.net - Carterra launches industry's first 48-channel HT-SPR platform for advanced label-free biomolecular screening and characterization
Carterra launches industry's first 48-channel HT-SPR platform for advanced label-free biomolecular screening and characterization
News-Medical

Carterra Inc., the leading provider of technologies enabling high-throughput biology, today announced the launch of the Carterra Vega High-Throughput Surface Plasmon Resonance (HT-SPR) instrument. The industry's first 48-channel SPR platform, Vega…

business-standard.com - Vrinda Goel - Q3 results today: Ashok Leyland, Lenskart, M&M among 344 firms on Feb 11
Q3 results today: Ashok Leyland, Lenskart, M&M among 344 firms on Feb 11
Business Standard

Ashok Leyland, Mahindra & Mahindra, LG Electronics, Lenskart Solutions, Max Financial, AstraZeneca Pharma, Kirloskar Oil Engines, and Godrej Industries are among 344 firms scheduled to announce their earnings report for the third quarter (Q3FY26)…

business-standard.com - Capital Market - Stock Alert: Titan Company, Eicher Motors, Apollo Hospitals Ent, Grasim Industries, Torrent Power
Stock Alert: Titan Company, Eicher Motors, Apollo Hospitals Ent, Grasim Industries, Torrent Power
Business Standard

Securities in F&O Ban: Sammaan Capital and Steel Authority of India (SAIL) shares are banned from F&O trading on 11 February 2026. Mahindra & Mahindra, LG Electronics India, Lenskart Solutions, Ashok Leyland, Aarey Drugs & Pharmaceuticals, Amagi…

business-standard.com - SI Reporter - Stock Market LIVE: GIFT Nifty hints at positive start amid mixed cues; Asian markets extend gains
Stock Market LIVE: GIFT Nifty hints at positive start amid mixed cues; Asian markets extend gains
Business Standard

Stock Market LIVE Updates, Wednesday, February 11, 2026: Indian equity benchmark indices, Sensex and Nifty, are likely to witness a positive opening on Wednesday amid mixed global cues. Around 6:50 AM, the GIFT Nifty was trading at 26,050.5 levels…

Receive a Daily briefing on Pharma Industry News

Get Started